De-Implementation Strategy for Mammogram Overuse in Aging Adults
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new approach to reduce unnecessary mammograms in women aged 75 and older. Researchers aim to determine if changing how doctors and patients perceive and use mammograms can decrease unneeded screenings. The trial includes two groups: one receives standard care with some improvements, while the other receives a comprehensive multilevel de-implementation strategy to reduce overuse. Women who speak English or Spanish, are 75 or older, and haven't had a mammogram in the last 6 months but did in the 7-18 months prior, might be a good fit.
As an unphased trial, this study offers a unique opportunity to contribute to research that could improve healthcare practices for older women.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on reducing mammogram overuse in older women, so it's best to discuss your medications with the trial team or your doctor.
What prior data suggests that this multilevel de-implementation strategy is safe for reducing mammogram overuse?
Research shows that the strategy under study aims to reduce unnecessary screening mammograms in women aged 75 and older. This approach changes behaviors and practices at various levels, including patients and healthcare providers, to improve mammogram decision-making.
Regarding safety, this strategy does not involve new drugs or medical procedures, so it poses no direct risks to physical health. Instead, it focuses on healthcare decision-making, which generally poses minimal risk to participants. No specific data on negative effects related to this strategy exist, as it primarily involves communication and decision-making processes. Overall, it is considered safe for those involved.12345Why are researchers excited about this trial?
Researchers are excited about the Multilevel De-Implementation Strategy because it aims to tackle the issue of mammogram overuse in older adults by focusing on reducing unnecessary screenings. Unlike the usual care approach, which often includes routine mammograms without considering individual patient needs, this strategy incorporates both provider and patient education to tailor decisions more closely to each patient's health status. By engaging at multiple levels—organizational, provider, and patient—this approach has the potential to optimize healthcare resources and improve patient outcomes by avoiding unnecessary procedures. This strategy could lead to more personalized care and reduce the risks and costs associated with over-screening.
What evidence suggests that this multilevel de-implementation strategy is effective for reducing mammogram overuse in aging adults?
This trial will compare two approaches to reduce mammogram overuse in aging adults. The Multilevel De-Implementation Strategy, used in one arm of this trial, involves both doctors and patients to help reduce unnecessary mammograms. Studies have shown that excessive mammograms in older women can lead to unnecessary stress and medical treatments. Surveys indicate that many older women feel pressured to have yearly mammograms due to their doctors' recommendations, even when the benefits at their age might be unclear. By addressing these issues, this strategy aims to reduce unwanted mammograms, improving care without risking health. Early studies suggest this approach could effectively balance the pros and cons of screening in older adults. Meanwhile, the other arm of this trial will receive Enhanced Usual Care, which includes organizational-level components of the strategy.13467
Who Is on the Research Team?
Parisa Tehranifar, DrPH
Principal Investigator
Columbia University
Rachel C Shelton, ScD, MPH
Principal Investigator
Columbia University
Nathalie Moise, MD, MS
Principal Investigator
Columbia University
Are You a Good Fit for This Trial?
This trial is for women aged 75 or older who speak English or Spanish, have a primary care visit scheduled in the next 2-4 weeks, and had a mammogram between 7-18 months ago but not in the last 6 months.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of multilevel de-implementation strategy at patient, provider, and organizational levels
Follow-up
Participants are monitored for changes in mammography screening practices and provider ordering behavior
What Are the Treatments Tested in This Trial?
Interventions
- Multilevel De-Implementation Strategy
Trial Overview
The study compares a new strategy to reduce unnecessary mammograms with usual care. Providers are randomly assigned to use either the multilevel de-implementation approach or enhanced usual care. Some strategies are used for all participants.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
The intervention group of providers and their patients from 2 clinics who are eligible for this study will receive the organizational level components of the multilevel de-implementation strategy (i.e., enhanced usual care as described above) as well as the provider and patient level components of the multilevel de-implementation strategy.
The enhanced usual care group of providers and their patients from 2 clinics who are eligible for this study will receive the organizational level components of the multilevel de-implementation strategy.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Columbia University
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Citations
A mixed-methods study of multi-level factors influencing ... - PMC
Survey findings show that 87.2% of older women believe it is important to plan for an annual mammogram, 80.8% received a provider recommendation, and 78.9% ...
Use of a Discrete Choice Experiment to Inform De ...
A mixed-methods study of multi-level factors influencing mammography overuse: implications for de-implementation. Implement Sci Commun. 2021 ...
De-Implementation Strategy for Mammogram Overuse in ...
This project aims to advance methodological and theoretical approaches for developing, selecting, refining, and piloting a multilevel ...
4.
researchgate.net
researchgate.net/publication/397061301_Multilevel_Predictive_Study_of_Breast_Cancer_Screening_Patterns_in_Pennsylvania_2021-2022Multilevel Predictive Study of Breast Cancer Screening ...
Results The study identified women in minority groups (aOR: 0.659, P < .01) have decreased odds of being screened for breast cancer, with the ...
Collaborative Modeling to Compare Different Breast ...
Benefits of DBT were comparable with those of digital mammography but resulted in fewer false-positive recalls and similar benign biopsies.
A Multi-Level Strategy for De-implementing Mammography ...
This project aims to advance methodological and theoretical approaches for developing, selecting, refining, and piloting a multilevel de-implementation ...
Division of Cancer Control & Population Sciences - Grant Details
Our preliminary research identified multi-level barriers and facilitators to de-implementation of mammography overuse among older women at the organizational ( ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.